Koninklijke Philips NV ADR(PHG) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 23 at 4:00 PM ET (Korea 10/24 05:00)
Full metrics table
| Index | - | P/E | 20.03 | EPS (ttm) | 1.34 | Insider Own | 0.01% | Shs Outstand | 977.4M | Perf Week | 4.47% |
| Market Cap | 26.28B | Forward P/E | 14.24 | EPS next Y | 2.21% | Insider Trans | - | Shs Float | 977.3M | Perf Month | 9.53% |
| Enterprise Value | 32.81B | PEG | 3.26 | EPS next Q | 0.39 | Inst Own | 5.27% | Short Float | 0.27% | Perf Quarter | 7.47% |
| Income | 1.30B | P/S | 1.28 | EPS this Y | -0.6% | Inst Trans | -0.37% | Short Ratio | 2.43 | Perf Half Y | -2.11% |
| Sales | 20.60B | P/B | 2.01 | EPS next 5Y | 4.37% | ROA | 4.21% | Short Interest | 2.61M | Perf YTD | -0.7% |
| Book/sh | 13.39 | P/C | 12.85 | EPS past 3/5Y | - -4.98% | ROE | 10.24% | 52W High | -19.58% ($33.44) | Perf Year | -7.31% |
| Cash/sh | 2.09 | P/FCF | 11.71 | Sales past 3/5Y | 2.42% 0.39% | ROIC | 6.39% | 52W Low | 13.84% ($23.62) | Perf 3Y | 47.68% |
| Dividend Est. | $0.98 (3.63%) | EV/EBITDA | 9.91 | EPS Y/Y TTM | 266.88% | Gross Margin | 45.93% | Volatility(W/M) | 1.36% 1.48% | Perf 5Y | -39.57% |
| Dividend TTM | 0.99 | EV/Sales | 1.59 | Sales Y/Y TTM | - | Oper. Margin | 9.12% | ATR (14) | 0.45 | Perf 10Y | 4.26% |
| Dividend Ex-Date | 2026/5/13 | Quick Ratio | 0.82 | EPS Q/Q | 62.15% | Profit Margin | 6.3% | RSI (14) | 71.35 | Recom | 2.29 |
| Dividend Gr. 3/5Y | - 0.73% | Current Ratio | 1.26 | Sales Q/Q | 3.1% | SMA20 | 7.53% ($25.01) | Beta | 0.73 | Target Price | $30 |
| Payout | 78.73% | Debt/Eq | 0.65 | Earnings | 2026/11/3 | SMA50 | 5.18% ($25.57) | Rel Volume | 1.25 | Prev Close | $26.92 |
| Employees | 66401 | LT Debt/Eq | 0.55 | EPS/Sales Surpr. | 38.88% 1.19% | SMA200 | -1.43% ($27.28) | Avg Volume(3M) | 1.07M | Price | $26.89 |
| IPO | 1980/3/17 | Option/Short | Yes/Yes | Trades | 6252 | Volume | 1,342,779 | Change | -0.11% |
🩺 A Netherlands-headquartered global health technology company that supplies medical imaging equipment—including magnetic resonance imaging (MRI), computed tomography (CT), X-ray, and ultrasound—as well as image-guided therapy, patient monitoring, and personal health devices to markets worldwide. It trades on US exchanges in ADR form and is a core holding in the medical devices and digital health cycle.
Over the past 1 year, roughly in the middle
20% below its 1-year high.
Traded about as much as usual. That is 125% of its average volume.
Next earnings report: November 3
8 days to go.
PHG earns at a steady pace
Of every $100 in sales, $9.12 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -0.6% this year.
Tap to view numbers
Within its industry, it looks cheap
Counting its debt, for $100 of yearly operating cash you would pay $991. Peers typically go for $1,594.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -39.6%. The S&P 500 did +68% over the same period.
Tap to view numbers
Dividends are paid consistently
Pays 3.63% annually in dividends.
Tap to view numbers
Institutions barely hold it
Institutions hold 5.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #8 of 143 in the industry
Based on market cap of $26B.
GEHC#6 GE HealthCare Technologies Inc $32B PER 16.4 
DXCM#7 Dexcom Inc $29B PER 30.8 PHG#8 Koninklijke Philips NV ADR $26B PER 20.0 
STE#9 Steris Plc $23B PER 28.4 
ZBH#10 Zimmer Biomet Holdings Inc $19B PER 24.0 
FAQ
What kind of company is PHG?
PHG belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of PHG?
The market cap of PHG is approximately $26.3B, ranking 512 within its sector.
Does PHG pay dividends?
PHG has a dividend yield of approximately 3.63%, with an annual dividend of $0.98.
What is the P/E ratio of PHG?
PHG has a P/E ratio of approximately 20.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for PHG?
PHG has recorded a 52-week high of $33.44 and a low of $23.62.
